| Application no. and date | 12784855.4 (espacenet) (Federated) (European Patent Register), 20121102 | | Patent/reg. no. and date | DK/EP 2776028, 20181017 | | Publication date | 20140917 | | Priority no. and date | US 201161555450 P, 20111103, US 201261616363 P, 20120327 | | EP pub. no. and date |
EP 2776028 20140917 | | Effective date | | | Applicant/owner | Ardea Biosciences, Inc., 4939 Directors Place
San Diego, CA 92121, US | | Applicant ref. no. | AstraZeneca UK Limited 200751-EP-EPT | | Inventor | QUART, Barry, D., 3273 Violet Ridge
Encinitas, CA 92024, US,
YEH, Li-tain, 6 Dos Rios
Irvine, CA 92602, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 19/00 (2006.01) , A61P 19/06 (2006.01) , A61P 9/12 (2006.01) | | Title | 3,4-DISUBSTITUERET PYRIDINFORBINDELSE, FREMGANGSMÅDER TIL ANVENDELSE DERAF OG SAMMENSÆTNINGER, DER OMFATTER DENNE | | Int. application no. | US2012063415 | | Int. publication no. | WO2013067425 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
